Rockledge Software, Inc. – Trademark Portfolio
Entity Type: 03
Rockledge Software, Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SALESPOINT. The owner is based in Nederland, CO.
P.O. Box 3100
Nederland, CO 80466
Showing of trademarks Trademarks
Trademark Classifications
Rockledge Software, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Rockledge Software, Inc. have?
Rockledge Software, Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned.
What trademark classes does Rockledge Software, Inc. file in?
Rockledge Software, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Rockledge Software, Inc.'s most well-known trademarks?
Rockledge Software, Inc.'s registered trademark portfolio includes well-known marks such as SALESPOINT. These are among 1 currently registered trademark in the portfolio.
What is Rockledge Software, Inc.'s trademark registration success rate?
Rockledge Software, Inc. has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.